Europe Needle-Free IV Connectors Market to Witness Robust Growth Due to Increasing Number of Needle-Stick Injuries
Needle-free IV connectors are medical devices that connect to the end of vascular catheters and enable catheter access for infusion and aspiration. The use of needle-free IV connectors reduces the risk of needle-stick injuries, and thus reduces the risk of blood borne infectious diseases. Thus, with increasing number of needle-stick injuries due to needle IV connectors, the demand for needle-free IV connectors is also increasing, driving the Europe needle-free IV connectors market growth. According to the healthmanagement.org, each year, around one million such injuries occur in the healthcare facilities across the European Union.
Moreover, in Europe, around 8 million healthcare workers are at risk of these injuries. One of the most common and serious risks to healthcare workers is an infection resulting from a sharp or needle-stick injury. This, in turn, is also expected to increase the demand for needle-free IV connectors. Several government organizations or regulatory bodies have also recommended the usage of these connectors to reduce the risk of blood stream infections and needle-stick injuries. This in turn is expected to augment growth of the Europe needle-free IV connectors market. Needleless connectors are used to improve the patient safety by reducing the number of needle-stick injuries and blood infections.
In the hospitals, needle-free connectors are used for intravenous administration of drugs and fluids to protect the central part of the vascular access systems. They help reduce the risk of potential contaminants associated with IV administration and prevent manipulation of all types of IV infections. Moreover, the Europe needle-free IV connectors market is witnessing robust growth due to rapid advancements in needleless connectors, such as connectors embedded with closed IV systems, and connectors preventing fluid reflux, are expected reduce the risk of bloodstream infections linked to IV administration. These IV connectors are suitable for all central, arterial, and peripheral venous catheters for the administration of drugs to patients.
Growth of the Europe needle-free IV connectors market is driven by the increasing catheter-related bloodstream infections and rising immunotherapy treatment for cancer, which are primarily administered through an IV infusion. Thus, with the increasing prevalence of cancer, the demand for needle-free IV connectors is also increasing. According to the World Health Organization (WHO), with more than 3.7 million new cases and 1.9 million deaths each year, cancer represents the second most leading cause of death and morbidity in Europe. This in turn is also expected to accelerate the Europe needle-free IV connectors market growth.
https://www.coherentmarketinsights.com/market-insight/europe-needle-free-iv-connectors-market-4261

Comments
Post a Comment